Recent Mendelian randomization studies have shown that patients with mutations in the ABCA1 gene (Tangier disease) are not at increased cardiovascular risk in the Copenhagen Heart Study [30] and many mutations within apo AI that cause a very low HDL-C and apo AI are not associated with premature CVD. This evidence concerns the gene APOA1 and Tangier disease.